CAS: 1421372-66-8 - AZD9291DA HCl salt
- Synonyms:
- Mutated EGFR-IN-1
- N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine
![N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,…](https://static.cymitquimica.com/products/AN/thumb/AG0039E9.jpg)
N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine
CAS:1421372-66-8
Formula:
C25H31N7O
Color and Shape:
Solid
Molecular weight:
445.5599
Ref: AN-AG0039E9
| Undefined size | To inquire |
Estimated delivery in United States, on Friday 9 Aug 2024
Mutated EGFR-IN-1
CAS:1421372-66-8
Mutated EGFR-IN-1 (Osimertinib analog) is a useful intermediate for the inhibitors design for mutated EGFR, …
Formula:
C25H31N7O
Purity:
99.73%
Color and Shape:
Solid
Molecular weight:
445.56
Ref: TM-T16162
| 1ml | 49.00 € | ||
| 25mg | 57.00 € | ||
| 50mg | 66.00 € | ||
| 100mg | 88.00 € | ||
| 200mg | 114.00 € | ||
| 500mg | 183.00 € |
Estimated delivery in United States, on Friday 9 Aug 2024
Ref: 4Z-A-194031
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Friday 16 Aug 2024
N1-2-(Dimethylamino) ethyl) - 5- methoxy- N1- methyl- N4- (4- (1- methyl- 1H- indol- 3- yl) pyrimidin- 2- yl) benzene- 1, 2, 4- tria mine
CAS:1421372-66-8
Intermediate in the synthesis of osimertinib (AZD9291)
Formula:
C25H31N7O
Purity:
Min. 95%
Molecular weight:
445.56 g/mol
Ref: 3D-FD162017
| 1mg | To inquire | ||
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Friday 20 Sep 2024
